Iltefat Hamzavi Selected Research

afamelanotide

7/2015	Afamelanotide for Erythropoietic Protoporphyria.
1/2015	Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
1/2013	The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iltefat Hamzavi Research Topics

Disease

17	Vitiligo 01/2022 - 06/2004
7	Hidradenitis Suppurativa 08/2022 - 08/2009
3	Hyperpigmentation 11/2021 - 02/2017
3	Erythema 11/2021 - 09/2019
3	Acne Vulgaris 11/2021 - 09/2011
2	COVID-19 03/2022 - 08/2021
2	Inflammation (Inflammations) 01/2022 - 10/2017
2	Blister (Bulla) 01/2021 - 04/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015 - 04/2013
1	Severe Acute Respiratory Syndrome 03/2022
1	Autoimmune Diseases (Autoimmune Disease) 11/2020
1	Pruritus (Itching) 11/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Melanosis (Freckles) 04/2019
1	Acne Keloid (Acne Keloidalis) 03/2018
1	Disease Progression 07/2017
1	Erythropoietic Protoporphyria 07/2015
1	Pain (Aches) 07/2015
1	Port-Wine Stain (Nevus Flammeus) 03/2012
1	Hemangioma (Angioma) 03/2012
1	Telangiectasis (Telangiectasia) 03/2012
1	Acanthosis Nigricans 06/2011
1	Tinea Versicolor (Pityriasis Versicolor) 04/2010
1	Hirsutism 07/2007
1	Neoplasms (Cancer) 01/2004
1	Skin Neoplasms (Skin Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

5	Melanins (Melanin)IBA 11/2021 - 02/2006
3	afamelanotideIBA 07/2015 - 01/2013
2	CytokinesIBA 01/2022 - 08/2021
2	ruxolitinibIBA 01/2022 - 11/2020
2	Biological ProductsIBA 08/2021 - 05/2021
2	Melanocyte-Stimulating Hormones (MSH)IBA 07/2015 - 01/2013
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2015 - 01/2004
2	Ficusin (Psoralen)IBA 01/2015 - 04/2013
1	Janus Kinase 1IBA 01/2022
1	Janus KinasesIBA 01/2022
1	brodalumabIBA 08/2021
1	Interleukin-1 (Interleukin 1)IBA 08/2021
1	SuspensionsIBA 01/2021
1	AntibodiesIBA 11/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 09/2019
1	Prostaglandins AIBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2017
1	Carbon DioxideIBA 01/2016
1	interleukin-21 (interleukin 21)IBA 05/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2015
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2013
1	MicroRNAs (MicroRNA)IBA 05/2013
1	Biomarkers (Surrogate Marker)IBA 05/2013
1	MelanocortinsIBA 01/2013
1	Hydroxy AcidsIBA 09/2011
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 09/2011
1	Insulin (Novolin)FDA Link 06/2011
1	AluminumIBA 08/2009
1	NeodymiumIBA 08/2009
1	YttriumIBA 08/2009
1	Eflornithine (Ornidyl)FDA Link 07/2007
1	Hemoglobins (Hemoglobin)IBA 02/2006
1	Verteporfin (Visudyne)FDA Link 01/2004

Therapy/Procedure

8	Therapeutics 08/2022 - 03/2012
8	Phototherapy (Light Therapy) 09/2019 - 06/2004
6	Lasers (Laser) 01/2021 - 07/2007
2	Skin Transplantation (Skin Grafting) 01/2021 - 04/2015
2	Photochemotherapy (Photodynamic Therapy) 01/2015 - 01/2004
1	Radiofrequency Therapy 04/2022
1	N95 Respirators 03/2022
1	Personal Protective Equipment 03/2022
1	Pain Management 01/2021
1	Autologous Transplantation 01/2021
1	Solid-State Lasers 03/2018
1	Transplantation 04/2015
1	Aftercare (After-Treatment) 04/2010
1	Intravenous Infusions 01/2004